PATENT CLAIM ANALYSIS

Application Number: 16201011
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["606", "152000"]

Abstract:
The present disclosure is directed to the use of fusogenic compounds such as polyethylene glycol (PEG) in combination with antioxidants, calcium-containing and calcium-free solutions for treating damaged nerves, such as for reconnecting severed nerves.

Claim (Index 29):
The method of  claim 23 , wherein the first period of time is about 60 seconds, the second period of time is about 90 seconds, the third period of time is about 90 seconds and the fourth period of time is about 120 to 180 seconds.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 98.0
- Lexical Diversity: 1.14706
- Patent Class: 606.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15597891', '14001431', '10812776', '10218864', '10218316']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7372705253917314
- 35 USC 102 Novelty (BERT): 0.5864919497838279
- Combined Prediction Score: 0.7221926678309412
- Mean Citation Score: 276.638074
- Max Citation Score: 511.98962
- Similarity Product: 484.8681605790162

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test